Property | Value |
?:abstract
|
-
The coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), warranting urgent study of the molecular mechanisms of SARS-CoV-2 infection and host immune response. Type I interferon (IFN-I) is a key component of host innate immune system responsible for eliminating the virus at the early stage of infection. In contrast, SARS-CoV-2 has evolved multiple strategies to evade innate immune response to facilitate viral replication, transmission, and pathogenesis. This review summarizes the recent progresses on SARS-CoV-2 proteins that antagonize host IFN-I production and/or signaling. These progresses have provided knowledge for new vaccine and antiviral development to prevent and control COVID-19.
|
is
?:annotates
of
|
|
?:creator
|
|
?:doi
|
|
?:doi
|
|
?:journal
|
-
J_Interferon_Cytokine_Res
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/9ecb783cf8aa133d126b6fd0067981754db7c820.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7757701.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2
|
?:type
|
|
?:year
|
|